Methods and reagents for vaccination which generate a CD8 T cell immune response
US6663871B1 · kind B1 · utility
21Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 1999 |
| Grant date | Dec 16, 2003 |
| Priority date | — |
| Expiry date | Dec 9, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New methods and reagents for vaccination are described which generate a CD8 T cell immune response against malarial and other antigens such as viral and tumour antigens. Novel vaccination regimes are described which employ a priming composition and a boosting composition, the boosting composition comprising a non-replicating or replication-impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.